Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/29/24 16:15 | 3/28/24 | FNCH | Health | BioPrd | Biological Products, (No Diag | Smisek Jeffery A | MA | D | S | -21 | 2.58 | 0 | -8 | -15 | 47 | M | |||||||||||||||
11/27/23 16:54 | 11/22/23 | FNCH | Health | BioPrd | Biological Products, (No Diag | Smisek Jeffery A | MA | D | S | -5 | 3.64 | 0 | -1 | -3 | 55 | D | |||||||||||||||
2/23/23 16:05 | 2/21/23 | FNCH | Health | BioPrd | Biological Products, (No Diag | Blaustein Marc | MA | O | COO | S | -2 | 0.3800 | 0 | -5 | -14 | 28 | D | ||||||||||||||
10/25/22 16:31 | 10/21/22 | FNCH | Health | BioPrd | Biological Products, (No Diag | Blaustein Marc | MA | O | COO | S | -5 | 1.39 | 0 | -4 | -10 | 33 | D | ||||||||||||||
10/25/22 16:25 | 10/21/22 | FNCH | Health | BioPrd | Biological Products, (No Diag | Vittiglio Joseph | MA | O | Chief Bu | S | -5 | 1.39 | 0 | -4 | -10 | 31 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |